{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:35:42Z","timestamp":1771054542031,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2075,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/mt.2010.271","type":"journal-article","created":{"date-parts":[[2010,12,7]],"date-time":"2010-12-07T15:23:47Z","timestamp":1291735427000},"page":"284-292","source":"Crossref","is-referenced-by-count":54,"title":["CNS-targeted Viral Delivery of G-CSF in an Animal Model for ALS: Improved Efficacy and Preservation of the Neuromuscular Unit"],"prefix":"10.1016","volume":"19","author":[{"given":"Alexandre","family":"Henriques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Pitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanjew","family":"Dittgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Klugmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2010.271_bib1","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(07)60944-1","article-title":"Amyotrophic lateral sclerosis","volume":"369","author":"Mitchell","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/mt.2010.271_bib2","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1471-4159.2006.04408.x","article-title":"Amyotrophic lateral sclerosis: all roads lead to Rome","volume":"101","author":"Gonzalez de Aguilar","year":"2007","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2010.271_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 1","key":"10.1038\/mt.2010.271_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"Rothstein","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1038\/mt.2010.271_bib5","first-page":"32","article-title":"Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?","volume":"4","author":"Henriques","year":"2010","journal-title":"Front Neurosci"},{"key":"10.1038\/mt.2010.271_bib6","first-page":"398","article-title":"Purification to apparent homogeneity and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor","volume":"29","author":"Welte","year":"1985","journal-title":"Haematol Blood Transfus"},{"key":"10.1038\/mt.2010.271_bib7","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1172\/JCI23559","article-title":"The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis","volume":"115","author":"Schneider","year":"2005","journal-title":"J Clin Invest"},{"issue":"Pt 12","key":"10.1038\/mt.2010.271_bib8","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/brain\/awn243","article-title":"Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis","volume":"131","author":"Pitzer","year":"2008","journal-title":"Brain"},{"key":"10.1038\/mt.2010.271_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-4159.2010.06659.x","article-title":"The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury","volume":"113","author":"Pitzer","year":"2010","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2010.271_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1471-4159.2006.03727.x","article-title":"Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease","volume":"97","author":"Meuer","year":"2006","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2010.271_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2202-11-25","article-title":"G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice","volume":"11","author":"Henriques","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.1038\/mt.2010.271_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-associated defective virus particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"key":"10.1038\/mt.2010.271_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/bjp.2008.349","article-title":"Viral vectors: from virology to transgene expression","volume":"157","author":"Bouard","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1038\/mt.2010.271_bib14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2008.60","article-title":"Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity","volume":"16","author":"Dodge","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.271_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2010.271_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.gt.3302895","article-title":"Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo","volume":"14","author":"Palomeque","year":"2007","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.271_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.brainres.2007.09.034","article-title":"Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS","volume":"1185","author":"Lepore","year":"2007","journal-title":"Brain Res"},{"key":"10.1038\/mt.2010.271_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ymthe.2005.01.006","article-title":"Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease","volume":"11","author":"Klugmann","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.271_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.1989.7.11.1685","article-title":"Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation","volume":"7","author":"Neidhart","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2010.271_bib20","series-title":"The Laboratory Mouse (The Handbook of Experimental Animals)","first-page":"278","author":"Hedrich","year":"2004"},{"key":"10.1038\/mt.2010.271_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/17482960903545334","article-title":"Guidelines for preclinical animal research in ALS\/MND: A consensus meeting","volume":"11","author":"Ludolph","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1038\/mt.2010.271_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"key":"10.1038\/mt.2010.271_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2010.271_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","article-title":"Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models","volume":"9","author":"Dupuis","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1038\/mt.2010.271_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cne.20620","article-title":"A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis","volume":"490","author":"Schaefer","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1038\/mt.2010.271_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2009.03.003","article-title":"Potentiation of angiogenesis and regeneration by G-CSF after sciatic nerve crush injury","volume":"382","author":"Pan","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2010.271_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.expneurol.2009.12.033","article-title":"Measuring nerve regeneration in the mouse","volume":"223","author":"Griffin","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2010.271_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-8993(98)01351-1","article-title":"Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene","volume":"819","author":"Warita","year":"1999","journal-title":"Brain Res"},{"key":"10.1038\/mt.2010.271_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.mt.6300367","article-title":"Efficient retrograde neuronal transduction utilizing self-complementary AAV1","volume":"16","author":"Hollis","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.271_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/mthe.2001.0520","article-title":"Targeted retrograde gene delivery for neuronal protection","volume":"5","author":"Kaspar","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.271_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.mcn.2004.10.002","article-title":"AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats","volume":"28","author":"Klugmann","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"10.1038\/mt.2010.271_bib32","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.77.12.7034-7040.2003","volume":"77","author":"Passini","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.271_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hum.2006.178","article-title":"Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain","volume":"18","author":"Taymans","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.271_bib34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.271_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.taap.2005.12.008","article-title":"Protection from the toxicity of diisopropylfluorophosphate by adeno-associated virus expressing acetylcholinesterase","volume":"214","author":"Li","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1038\/mt.2010.271_bib36","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/mt.2010.97","article-title":"Transient demyelination increases the efficiency of retrograde AAV transduction","volume":"18","author":"Hollis","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.271_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1038\/mt.2010.271_bib38","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":"Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"key":"10.1038\/mt.2010.271_bib39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/hum.2007.022","article-title":"Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial","volume":"18","author":"Moss","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.271_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000306309.85301.e2","article-title":"Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D","volume":"71","author":"Rodino-Klapac","year":"2008","journal-title":"Neurology"},{"key":"10.1038\/mt.2010.271_bib41","first-page":"240","article-title":"CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease","volume":"12","author":"Mandel","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"10.1038\/mt.2010.271_bib42","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2010.271_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2010.271_bib44","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nbt1007-1111","article-title":"AAV vectors and tumorigenicity","volume":"25","author":"Kay","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2010.271_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1167\/iovs.09-3847","article-title":"Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys","volume":"51","author":"Buie","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/mt.2010.271_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.expneurol.2007.08.001","article-title":"Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?","volume":"209","author":"Kordower","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2010.271_bib47","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.271_bib48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nn1653","article-title":"Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF","volume":"9","author":"Pun","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1038\/mt.2010.271_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2010.07.002","article-title":"Restoration of microglial function by granulocyte-colony stimulating factor in ALS model mice","volume":"229","author":"Yamasaki","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1038\/mt.2010.271_bib50","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1523\/JNEUROSCI.3494-08.2008","article-title":"Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase","volume":"28","author":"Gowing","year":"2008","journal-title":"J Neurosci"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616323863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616323863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T10:51:42Z","timestamp":1544093502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616323863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1525001616323863"],"URL":"https:\/\/doi.org\/10.1038\/mt.2010.271","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}